May 20, 2013 - PORTLAND, Ore. -- Sedia Biosciences Corporation of Portland Oregon, U.S.A., announced today the global launch of a new assay, the Sediaa HIV-1 Limiting Antigen Avidity Enzyme Immunoassay to epidemiologists, researchers and public health care scientists seeking an accurate laboratory tool to identify recent infections previously ... (more)
http://www.prlog.org/12139840-sedia-biosciences-announces-global-launch-of-new-research-assay-to-detect-recent-hiv-1-infections.html
http://www.prlog.org/12139840-sedia-biosciences-announces-global-launch-of-new-research-assay-to-detect-recent-hiv-1-infections.html
No comments:
Post a Comment